KD Logo

Astria Therapeutics Inc [ATXS] stock was sold by Morabito Christopher at the price of US$0.14 million

Astria Therapeutics Inc’s recent filing unveils that its Chief Medical Officer Morabito Christopher unloaded Company’s shares for reported $0.14 million on Apr 01 ’24. In the deal valued at $13.59 per share,10,000 shares were sold. As a result of this transaction, Morabito Christopher now holds 0 shares worth roughly $0.0.

Then, PERCEPTIVE ADVISORS LLC bought 2,481,350 shares, generating $29,999,522 in total proceeds. Upon buying the shares at $12.09, the Director now owns 4,873,721 shares.

Before that, Morabito Christopher sold 9,200 shares. Astria Therapeutics Inc shares valued at $102,552 were divested by the Chief Medical Officer at a price of $11.15 per share. As a result of the transaction, Morabito Christopher now holds 0 shares, worth roughly $0.0.

Evercore ISI initiated its Astria Therapeutics Inc [ATXS] rating to an Outperform in a research note published on March 28, 2023; the price target was $18.

Price Performance Review of ATXS

On Friday, Astria Therapeutics Inc [NASDAQ:ATXS] saw its stock fall -4.00% to $10.81. Over the last five days, the stock has lost -4.08%. Astria Therapeutics Inc shares have risen nearly 40.76% since the year began. Nevertheless, the stocks have fallen -9.62% over the past one year. While a 52-week high of $16.90 was reached on 03/25/24, a 52-week low of $4.26 was recorded on 01/05/24. SMA at 50 days reached $13.90, while 200 days put it at $8.94. A total of 0.59 million shares were traded, compared to the trading of 0.77 million shares in the previous session.

Levels Of Support And Resistance For ATXS Stock

The 24-hour chart illustrates a support level at 10.43, which if violated will result in even more drops to 10.05. On the upside, there is a resistance level at 11.26. A further resistance level may holdings at 11.71. The Relative Strength Index (RSI) on the 14-day chart is 31.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.16%. Stochastics %K at 6.15% indicates the stock is a buying.

Most Popular

[the_ad id="945"]